GHIT Fund Invests JPY 140 Million in Portable Rapid Diagnostic System for Ebola Disease

The Global Health Innovative Technology (GHIT) Fund has invested approximately JPY 140 million ($862,000) to support the development of a portable rapid diagnostic system for detecting the Bundibugyo virus strain of Ebola. The project is being jointly developed by Osaka Metropolitan University, K.K. DNAFORM, and INRB in the Democratic Republic of the Congo.

By GHIT Fund · PR Newswire · July 23, 2026, 04:01 UTC

Topics: diagnostic tools Ebola GHIT Fund investment public health emergency

Read the full article at PR Newswire

More Health news

Data Suggests United States May Lose Measles Elimination Status The Verge · November 11, 2026, 19:48 UTC
Rising U.S. Measles Outbreaks Pose Significant Economic Burden CNBC · November 11, 2026, 12:00 UTC
FDA Issues Not Approvable Letter for NovoCure's Optune Mya Motley Fool · November 10, 2026, 18:50 UTC
Immunovant Reports Q2 2026 Financial Results and IMVT-1402 Clinical Data Motley Fool · November 10, 2026, 01:43 UTC
Royalty Pharma Poised to Benefit from Revolution Medicines' FDA-Approved Pancreatic Cancer Drug Motley Fool · November 8, 2026, 15:15 UTC
Acumen Pharmaceuticals Expects Phase II Alzheimer's Trial Results in November 2026 Motley Fool · November 5, 2026, 01:48 UTC
Moderna and Merck Face Manufacturing Challenges for Promising Personalized Cancer Vaccine Motley Fool · November 3, 2026, 20:52 UTC
Amgen's Imdelltra Shows Significant Efficacy in Advanced Lung Cancer Treatment Motley Fool · November 2, 2026, 17:25 UTC
American Association for Physician Leadership Releases New Book on Systems Thinking and Strategic Change PR Newswire · October 30, 2026, 12:51 UTC
Pennsylvania Reports Nearly 1,400 Measles Cases and Five Deaths Seeking Alpha · October 29, 2026, 16:18 UTC